(SSE:688399)
Since its founding in 2010, BioPerfectus has been dedicated to providing molecular diagnostic solutions specializing in emerging infectious diseases for generations and generations to come. We are leading the change by offering Real-Time PCR Kits, Nucleic Acid Extraction Systems, Automation Solutions, and Rapid Tests to laboratories, hospitals, institutions, and CDCs across the globe. BioPerfectus products have been distributed to more than 100 countries around the world. As one of the leading global IVD suppliers, BioPerfectus is committed to delivering excellent services and products that meet the highest international quality and safety standards. Our global presence enables us to build close relationships with our clients and leverage our expertise to support them worldwide.
An industrial park of over 62,000㎡ integrating fully self-innovative R&D, production, warehousing, logistics, sales, marketing and customer service divisions catering for various business scenarios
Over 800 Bioperfectus people’s permission gathering the perseverance and determination to fight against the global pandemic
Production capacity ramping up to more than 5 million tests/day ensuring the quick sufficient response to infectious diseases
90 Countries within a year
Bioperfectus Products & Service have been distributed to over 80+ countries around the globe within only one year since the international business established.
20000 Installation base
Bioperfectus Nucleic Acid Extraction Solutions
were launched in over 20,000 laboratories
globally with a well-trained and quick-response
customer service team.